Search research articles
Contact Us
Filters
Showing results (431-440 of 505) with videos related to
Page
of 51
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 2, 2007
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors
Francis Beaulieu, Carl Ouellet, Edward H Ruediger, et al.
Plos One
|
December 31, 2013
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells
Stefania Fiorcari, Wells S Brown, Bradley W McIntyre, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2002
C-3 Amido-indole cannabinoid receptor modulators
John Hynes, Katerina Leftheris, Hong Wu, et al.
The Journal of Biological Chemistry
|
May 25, 2013
Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion
Peter Vanderslice, Ronald J Biediger, Darren G Woodside, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 30, 2010
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease
Christopher W McIntyre, Laura E A Harrison, M Tarek Eldehni, et al.
Plos One
|
July 26, 2017
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
Kathleen M Gillooly, Claudine Pulicicchio, Mark A Pattoli, et al.
Nephron. Clinical Practice
|
April 23, 2014
Knowing what we do and doing what we should: quality assurance in hemodialysis
Maria Alquist, Juan P Bosch, Claudia Barth, et al.
Molecular Cancer Research : MCR
|
January 23, 2013
Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis
Yu-Chen Lee, Jung-Kang Jin, Chien-Jui Cheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors
Jagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 2, 2007
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors
Makonen Belema, Amy Bunker, Van N Nguyen, et al.
Page
of 51
Search research articles
Search
Showing results (431-440 of 505) with videos related to
Sort By:
Page
of 51
Bioorganic & Medicinal Chemistry Letters
|
January 2, 2007
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors
Francis Beaulieu, Carl Ouellet, Edward H Ruediger, et al.
Plos One
|
December 31, 2013
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells
Stefania Fiorcari, Wells S Brown, Bradley W McIntyre, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2002
C-3 Amido-indole cannabinoid receptor modulators
John Hynes, Katerina Leftheris, Hong Wu, et al.
The Journal of Biological Chemistry
|
May 25, 2013
Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion
Peter Vanderslice, Ronald J Biediger, Darren G Woodside, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 30, 2010
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease
Christopher W McIntyre, Laura E A Harrison, M Tarek Eldehni, et al.
Plos One
|
July 26, 2017
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
Kathleen M Gillooly, Claudine Pulicicchio, Mark A Pattoli, et al.
Nephron. Clinical Practice
|
April 23, 2014
Knowing what we do and doing what we should: quality assurance in hemodialysis
Maria Alquist, Juan P Bosch, Claudia Barth, et al.
Molecular Cancer Research : MCR
|
January 23, 2013
Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis
Yu-Chen Lee, Jung-Kang Jin, Chien-Jui Cheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors
Jagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 2, 2007
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors
Makonen Belema, Amy Bunker, Van N Nguyen, et al.
Page
of 51